| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |